Liquid Dosage
Therapeutical Proteins
Protein-based therapeutics are increasingly being developed as new chemical entities in the pharmaceutical and life science industries. Unlike small molecules, which are typically synthesized using chemical processes, most proteins need to be processed in living systems, mostly by recombinant DNA technology. The proteins can then be produced in their functional form (quaternary structure), rather than by microbial biosynthesis (bacteria/yeast), substantially reducing the downstream stages of the process.
The GEA Advantage
As the demand for large-volume products increases, so does the requirement for higher capacity reactors (up to 20,000 L) to realize economies of scale. GEA has responded to the changing needs of biopharmaceutical manufacturers and developed improved technology solutions to optimize both upstream and, with increasing titers, downstream processing, in terms of time and cost efficiency.
Based on its history of innovation and process development, GEA has a thorough working knowledge of therapeutic protein production and has used this competence to design better media and feeding strategies, optimize the fermentation stage and enhance physicochemical conditions during the manufacturing process.
A leading international supplier of integrated process systems, our extensive portfolio of products, technologies and services includes standard and customized fermenters, separators and entire production lines, as well as plant for the production, storage and distribution of clean utilities. Systems for the preparation of media, fluid management, cell cultivation and purification are also part of our global scope of supply.
As a competent manufacturer of complete plant for the life science industries, GEA is a full-service provider of solutions that meet your exact requirements and specifications. From planning, development and installation to qualification and maintenance, our experienced engineers will collaborate with your project team to supply innovative and efficient process solutions for your applications.
Produtos e Tecnologias
Mostrando 4 de 12
Bloco de compressão homogeneizador
As cabeças de compressão da GEA são o centro pulsante do homogeneizador, pois podem ativar o processo de homogeneização, bombeando o produto em alta pressão até que ele flua dentro da válvula de homogeneização.
Homogeneizadores industriais
Os homogeneizadores industriais da GEA são máquinas formadas por dois elementos essenciais: um bloco de compressão, que permite bombear o produto em alta pressão e uma válvula de homogeneização, capazes de micronizar as partículas dispersas para a ordem de micrômetros e nanômetros, dependendo das características do produto e dos resultados deseja...
Homogeneizadores laboratoriais
Os homogeneizadores de laboratório da GEA, pequenos e compactos, permitem testar os efeitos da homogeneização no produto e avaliar quais são os melhores parâmetros de processo.
Homogeneizadores montados sobre plataformas
Já por algum tempo a GEA estabelece o padrão para as unidades do homogenizador de alta pressão (VHP) para aplicações farmacêuticas e de biotecnologia. Nosso objetivo de fornecimento vai de máquinas de bancada de laboratório a projeto in-house e fabricação em escala piloto e sistemas integrados para produção de ruptura celular e aplicações de red...
Downloads
Insights da GEA
All pharmaceutical freeze-drying vials are the same! Aren't they?
Whether it’s a fad or the future, 100% vial traceability is becoming an increasingly important consideration in the pharmaceutical freeze drying industry. Keeping a close eye on developments is GEA. We’re investigating possible solutions and, what’s more, we have the experience, expertise and know-how to implement them.
Cerveja sem álcool: Eles querem tudo - eles querem menos
Houve um tempo em que as frases "cerveja sem álcool" e "bom sabor" raramente eram usadas juntas na mesma frase, particularmente pelos consumidores. Mas as cervejas sem álcool e de baixo teor de álcool percorreram um longo caminho - muitas delas agora são bebidas refrescantes por direito próprio - graças, em grande parte, à tecnologia da GEA.
Innovating patient care with aseptic spray drying
At GEA, our commitment to engineering for a better world fuels our pursuit of innovative solutions that enhance patient care and safety. One of our most promising ventures in recent years is aseptic spray drying – a technology that promises to revolutionize pharmaceutical manufacturing.
